ELUT Q2 2025 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-0.4% YoY

Gross Profit

$3M48.8% margin

Operating Income

-$10M-157.7% margin

Net Income

-$10M-153.4% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+3.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$34M

Total Liabilities

$76M

Stockholders' Equity

-$42M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	-0.4%
Gross Profit	$3M	$3M	+9.3%
Operating Income	-$10M	-$9M	-16.0%
Net Income	-$10M	-$28M	+65.9%

Revenue Segments

Women's Health

$2M73%

Cardiovascular

$736,00027%